Dehydrogenases, the derivatives thereof, and method for the production of optically active alkanols
The present invention relates to proteins having an enzymatic activity of reducing substituted alkanones such as 3-methylamino-1-(2-thienyl)-propan-1-one. The invention furthermore relates to nucleic acids coding for said proteins, nucleic acid constructs, vectors, genetically modified microorganisms and to methods for preparing optically active substituted alkanols, such as, for example, (S)-3-methylamino-1-(2-thienyl)-(S)-propanol.
1. A method for the microbiological preparation of a substituted alkanol of formula I
in which
n is an integer from 0 to 5;
Cyc is an optionally-substituted mononuclear or polynuclear, saturated or unsaturated, carbocyclic or heterocyclic ring, and
R 1 is a halogen, SH, OH, NO 2 , NR 2 R 3 or NR 2 R 3 R 4+ X − , whereby R 2 , R 3 and R 4 independently are H or a lower alkyl or a lower alkoxy radical and X − is a counterion,
wherein, in a medium comprising an alkanone of formula II
in which n, Cyc and R 1 are as defined above, the method comprises
a) culturing a microorganism, whereby the microorganism produces a dehydrogenase having the amino acid sequence of SEQ ID NO: 2, and wherein the dehydrogenase reduces 3-methylamino-1-(2-thienyl)-propan-1-one to the corresponding S-alcohol with at least 50% of the activity of the dehydrogenase having the amino acid sequence of SEQ ID NO: 2, or
b) incubating the dehydrogenase of a), whereby the dehydrogenase catalyzes enzymatic reduction of the compound of formula II to the compound of formula I; and
c) isolating the reduced compound of formula I.
2. The method of claim 1 , wherein the dehydrogenase catalyzes enantioselective synthesis of the compound of formula I.
3. The method of claim 1 , wherein the compound of formula I is 3-methylamino-1-(2-thienyl)-(S)-propanol of formula III
and the compound of the formula II is 3-methylamino-1-(2-thienyl)-propan-2-one of formula IV
and the isolated reduced compound of formula I is essentially enantiomerically pure.
4. The method of claim 1 , wherein the dehydrogenase is encoded by a nucleic acid comprising a nucleic acid sequence that is at least 80% identical to the nucleic acid sequence of SEQ ID NO: 1.
5. The method of claim 1 , wherein the culturing or incubating is carried out with an addition of reduction equivalents or is carried out under conditions in which reduction equivalents consumed are regenerated.
6. The method of claim 1 , wherein the microorganism is selected from the group consisting of the families Enterobacteriaceae, Pseudomonadaceae, Rhizobiaceae, Streptomycetaceae and Nocardiaceae.
7. The method of claim 1 , wherein the microorganism is a recombinant microorganism that has been transformed with a nucleic acid construct coding for the dehydrogenase.
8. The method of claim 1 , wherein the method comprises preparing Duloxetine.
9. The method of claim 3 , wherein the method comprises preparing Duloxetine.
10. The method of claim 4 , wherein the nucleic acid comprises the nucleic acid sequence of SEQ ID NO: 1.